Small nanobody drugs win big backing from pharma.Published in:Nature Medicine, 2013, v. 19, n. 11, p. 1355, doi. 10.1038/nm1113-1355By:Williams, Sarah CPPublication type:Article
Ablynx checkpoint agents lure Merck.Published in:Nature Biotechnology, 2014, v. 32, n. 4, p. 298, doi. 10.1038/nbt0414-298By:Sinha, GunjanPublication type:Article
Public companies get creative in raising finance.Published in:Nature Biotechnology, 2010, v. 28, n. 4, p. 301, doi. 10.1038/nbt0410-301By:Hodgson, JohnPublication type:Article